REVAM: Body Image Disorder in Anorexia Nervosa and Virtual Reality

Sponsor
University Hospital, Brest (Other)
Overall Status
Terminated
CT.gov ID
NCT03118921
Collaborator
(none)
17
1
1
30.4
0.6

Study Details

Study Description

Brief Summary

Evaluation of the tolerance and acceptability of the virtual representation of its body image.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual reality
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
17 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Body Image Disorder in Anorexia Nervosa and Virtual Reality
Actual Study Start Date :
Apr 20, 2017
Actual Primary Completion Date :
Oct 31, 2019
Actual Study Completion Date :
Oct 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual reality

The first session aims to present the virtual reality material that will be used. The second session will take place 2 weeks after the first session and will consist of the use of the immersion software

Device: Virtual reality
The first session aims to present the virtual reality material that will be used. The second session will take place 2 weeks after the first session and will consist of the use of the immersion software.

Outcome Measures

Primary Outcome Measures

  1. Self-questionnaire assessing tolerance [Day 15]

    Patients will have to respond to a self-administered questionnaire assessing tolerance

  2. Self-questionnaire assessing acceptability [Day 15]

    Patients will have to respond to a self-administered questionnaire assessing acceptability

Secondary Outcome Measures

  1. Feeling of presence [Day 15]

    Patients will respond to a self-questionnaire of feeling of presence

  2. Subjective experience by EDI-2 questionnaire [Day 15]

    Pre- and post-test comparison of body dissatisfaction by EDI-2 questionnaire.

  3. Subjective experience by BSQ questionnaire [Day 15]

    Pre- and post-test comparison of body dissatisfaction by BSQ questionnaire.

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women, aged between 16 and 40

  • Post-puberty

  • Pure restrictive anorexia nervosa, diagnosis by the DSM-V

  • BMI <17.5

  • Patient attending an outpatient clinic at the Bohars Psychiatric Hospital in France

  • Having signed the Informed Consent Form

  • For minor patients, signing the form of informed consent of both parents

Exclusion Criteria:
  • Associated eating disorder (bulimia, or the binge eating / purging form of anorexia nervosa),

  • Psychiatric disorders (characterized depressed, anxiety disorder)

  • Neurological Disorders

  • Mental retardation

  • Abuse or addiction to alcohol

  • Abuse or dependence on psychoactive substances in the previous year.

  • Patient with a protective justice measure

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHRU Brest Brest France 29200

Sponsors and Collaborators

  • University Hospital, Brest

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT03118921
Other Study ID Numbers:
  • REVAM
First Posted:
Apr 18, 2017
Last Update Posted:
Dec 28, 2021
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 28, 2021